CBD Life Sciences, Inc. (CBDL) Announces Bladder Control SCOTTSDALE, AZ / ACCESSWIRE / September 21, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company is working towards launching a bladder control supplement.
LBC Bioscience Inc's Research Department is effectively doing a study on a particular supplement pertaining to control of the bladder. The company has shifted its focus towards this product because it has never been seen or done before! President & CEO Lisa Nelson states "This product will be all natural derived from herbs in veggie capsules infused with CBD and contain 500MG!" Lisa Nelson also states, "The overall goal is to create a product that can be a sleep aid along with stress relief and bladder control throughout the night." Once research is finalized, the supplement will be ready to hit the shelves and CBD Life Sciences Inc. will keep the public informed on this exciting topic moving forward!
Out of all cannabinoids, cannabidiol is most widely used for therapeutic reasons due to the lack of psychoactive effects. In several medical applications, cannabidiol oil is used. Due to the increasing adoption of CBD-based products to treat ailments, the global cannabidiol market is anticipated to grow at a lucrative rate over the forecast period. Increasing awareness of cannabidiol's therapeutic benefits has influenced a buyer to buy cannabidiol products, regardless of their cost. As these have a greater profit margin, commercial retailers are now focusing on selling cannabis-based products. Numerous health and wellness retailers are offering CBD-based products, such as Rite Aid, CVS Health, and Walgreens Boots Alliance. In addition, CVS Health decides to offer CBD topicals all over its 800 stores and Walgreens Boots Alliance is selling CBD-containing topicals across 1500 of its stores in the U.S. Report from Fortune Business Insights said that the global cannabidiol (CBD) market size was USD 2,770.8 million in 2020. They also stated that the market is projected to grow from USD 3,675.1 million in 2022 to USD 55,791.3 million in 2028 at a CAGR of 47.49% between 2022 and 2028.
The number of benefits CBD has is tremendous! These benefits may help with behavioral/neurological complications such as ADD/ADHD, anxiety, autism, bipolar, OCD, PTSD, epilepsy, Parkinson's, osteoporosis, and ALS. CBD may also benefit pain management that can stem from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD has been found to also have gastrointestinal benefits with gastro-disorders and complications such as anorexia, cachexia, Crohn's, diabetes, and nausea. Physical complications/disorders such as muscular dystrophy and even immune system-based deficiencies and other complications such as cancer and hypertension even our bodies way and ability to maintain homeostasis have all been said to benefit from CBD.
https://www.accesswire.com/716796/cbd-life-sciences-inc-cbdl-announces-bladder-control-supplement